Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study

Published 2017 View Full Article

Authors

Keywords

Journal

HAEMATOLOGICA

Volume 102, Issue 8, Pages 1368-1377

Publisher

Ferrata Storti Foundation (Haematologica)

Online

2017-05-19

DOI

10.3324/haematol.2017.165001

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

HAEMATOLOGICA

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.